Deborah Miller (NUVL) plans sale of 21,000 shares on Nasdaq

Rhea-AI Filing Summary

Nuvalent insider Deborah Miller has filed a Form 144 notice to sell up to 21,000 shares of Nuvalent common stock. The shares are to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services, with an approximate sale date of 01/22/2026. The filing notes that 67,271,461 common shares were outstanding.

The 21,000 shares were acquired on 01/22/2026 via a cash exercise of stock options from the issuer. The notice also lists recent sales of Nuvalent common stock over the past three months, including 24,200 shares sold on 11/17/2025 and 21,800 shares sold on 10/30/2025, some under Rule 10b5-1 trading arrangements. By signing, the seller represents that she is not aware of undisclosed material adverse information about the company.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21000	2289840.00	67271461	01/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/22/2026	Exercise of Stock Options	Issuer			21000	01/22/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DEBORAH MILLER One Broadway, 14th Floor Cambridge MA 02142	Common	01/21/2026	700	76890.03
DEBORAH MILLER One Broadway, 14th Floor Cambridge MA 02142	Common	01/06/2026	2589	251559.68
DEBORAH MILLER One Broadway, 14th Floor Cambridge MA 02142	Common	01/05/2026	4363	424597.91
10b5-1 Sales for DEBORAH MILLER One Broadway, 14th Floor Cambridge MA 02142	Common	01/02/2026	10000	1005076.00
10b5-1 Sales for DEBORAH MILLER One Broadway, 14th Floor Cambridge MA 02142	Common	11/17/2025	24200	2553011.20
10b5-1 Sales for DEBORAH MILLER One Broadway, 14th Floor Cambridge MA 02142	Common	10/30/2025	21800	2248903.68

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NUVL Form 144 filing by Deborah Miller disclose?

The Form 144 filing discloses that Deborah Miller plans to sell up to 21,000 shares of Nuvalent common stock on the NASDAQ, following acquisition of those shares through a cash exercise of stock options on 01/22/2026.

How many Nuvalent (NUVL) shares are covered by this planned sale?

The notice covers up to 21,000 shares of Nuvalent common stock to be sold, with an approximate sale date of 01/22/2026.

How did Deborah Miller acquire the Nuvalent (NUVL) shares she plans to sell?

The filing states that the 21,000 shares to be sold were acquired on 01/22/2026 through an exercise of stock options from the issuer, paid for in cash.

Which broker is handling the planned sale of NUVL shares?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with the shares listed on the NASDAQ.

How many Nuvalent (NUVL) shares were outstanding according to the Form 144?

The Form 144 notes that 67,271,461 shares of Nuvalent common stock were outstanding at the time referenced in the notice.

What recent Nuvalent (NUVL) stock sales by Deborah Miller are disclosed in the last 3 months?

The filing lists several sales of Nuvalent common stock in the prior three months, including 24,200 shares sold on 11/17/2025 and 21,800 shares sold on 10/30/2025, among other transactions, some identified as 10b5-1 sales.

What representation does the seller make in the NUVL Form 144?

By signing, the seller represents that she does not know any material adverse information about Nuvalent's current or prospective operations that has not been publicly disclosed, and, if relying on a Rule 10b5-1 plan, makes that representation as of the plan adoption or instruction date.